LIVE
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoin. Track ONESOURCE SPECL PHARMA L's live NSE:ONESOURCE share price ₹1,589.70 (-1.85%), market cap ₹₹182B. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for ONESOURCE — real-time NSE India stock intelligence.
Open
₹1,624.00
High
₹1,624.00
Low
₹1,577.90
Prev. Close
₹1,619.70
52W High
₹1,946.10
52W Low
₹1,057.00
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoin
Key Takeaway
ONESOURCE SPECL PHARMA L is rated buy with a P/E of —x — understand the valuation context before sizing a position.
★ Recommended
Ask AI: Is ONESOURCE SPECL PHARMA L fairly valued right now?
Because a P/E of —x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting ONESOURCE SPECL PHARMA L
Because the investment case must account for macro and company-specific developments — events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Healthcare moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
449 Cr
Revenue
25 Cr
Net Profit
0%
ROE
0%
ROCE
-4.21
EPS
| ₹ in Crore | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 39 | 172 | 1,445 | 1,422 | 1,543 |
| Net Profit | -800 | -391 | -18 | -74 | -49 |
| ROE (%) | — | — | — | 0.0% | 0.0% |
| EPS (₹) | — | — | — | -4.21 | -4.21 |
| Debt/Equity | — | — | — | 25.8 | 25.8 |